 PLANEGG, GERMANY ACCESSWIRE June 16, 2021 MorphoSys AG FSE:MORNASDAQ:MOR MorphoSys today announced that it is commencing a cash tender offer to purchase all outstanding shares of Constellation Pharmaceuticals, Inc., CNST Constellation for 34.00 per share, net to the seller in cash, without interest, and subject to any applicable withholding of taxes. The tender offer is being made pursuant to the previously announced merger agreement, dated June 2, 2021 between MorphoSys and Constellation. 